Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 165

1.

Occupational exposure to herbs containing aristolochic acids increases the risk of urothelial carcinoma in Chinese herbalists.

Yang HY, Wang JD, Lo TC, Chen PC.

J Urol. 2013 Jan;189(1):48-52. doi: 10.1016/j.juro.2012.08.090. Epub 2012 Nov 16.

PMID:
23164394
2.

Editorial comment.

Landrigan PJ.

J Urol. 2013 Jan;189(1):52. doi: 10.1016/j.juro.2012.08.263. Epub 2012 Nov 16. No abstract available.

PMID:
23164374
3.

Occupational kidney disease among Chinese herbalists exposed to herbs containing aristolochic acids.

Yang HY, Wang JD, Lo TC, Chen PC.

Occup Environ Med. 2011 Apr;68(4):286-90. doi: 10.1136/oem.2010.058594. Epub 2010 Oct 8.

PMID:
20935286
4.

Increased risks of upper tract urothelial carcinoma in male and female chinese herbalists.

Yang HY, Wang JD, Lo TC, Chen PC.

J Formos Med Assoc. 2011 Mar;110(3):161-8. doi: 10.1016/S0929-6646(11)60026-0.

5.

Association of blood lead and mercury with estimated GFR in herbalists after the ban of herbs containing aristolochic acids in Taiwan.

Lin HH, Chou SA, Yang HY, Hwang YH, Kuo CH, Kao TW, Lo TC, Chen PC.

Occup Environ Med. 2013 Aug;70(8):545-51. doi: 10.1136/oemed-2012-101066. Epub 2013 May 23.

PMID:
23703822
6.

Risks of kidney failure associated with consumption of herbal products containing Mu Tong or Fangchi: a population-based case-control study.

Lai MN, Lai JN, Chen PC, Hsieh SC, Hu FC, Wang JD.

Am J Kidney Dis. 2010 Mar;55(3):507-18. doi: 10.1053/j.ajkd.2009.10.055. Epub 2010 Feb 8.

PMID:
20116155
7.

Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk.

Lai MN, Wang SM, Chen PC, Chen YY, Wang JD.

J Natl Cancer Inst. 2010 Feb 3;102(3):179-86. doi: 10.1093/jnci/djp467. Epub 2009 Dec 21.

8.

Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi)

Nortier JL, Martinez MC, Schmeiser HH, Arlt VM, Bieler CA, Petein M, Depierreux MF, De Pauw L, Abramowicz D, Vereerstraeten P, Vanherweghem JL.

N Engl J Med. 2000 Jun 8;342(23):1686-92.

9.

Re: Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk.

Su YC, Lin JS, Lee MT, Li TC, Lee SM.

J Natl Cancer Inst. 2010 Jul 7;102(13):988; author reply 988-90. doi: 10.1093/jnci/djq180. Epub 2010 May 17. No abstract available.

PMID:
20479292
10.

Late onset of bladder urothelial carcinoma after kidney transplantation for end-stage aristolochic acid nephropathy: a case series with 15-year follow-up.

Lemy A, Wissing KM, Rorive S, Zlotta A, Roumeguere T, Muniz Martinez MC, Decaestecker C, Salmon I, Abramowicz D, Vanherweghem JL, Nortier J.

Am J Kidney Dis. 2008 Mar;51(3):471-7. doi: 10.1053/j.ajkd.2007.11.015.

PMID:
18295063
11.

Chinese herbal uropathy and nephropathy.

Laing C, Hamour S, Sheaff M, Miller R, Woolfson R.

Lancet. 2006 Jul 22;368(9532):338. No abstract available.

PMID:
16860704
12.

Invasive urothelial carcinoma after exposure to Chinese herbal medicine containing aristolochic acid may occur without severe renal failure.

Nortier JL, Schmeiser HH, Muniz Martinez MC, Arlt VM, Vervaet C, Garbar CH, Daelemans P, Vanherweghem JL.

Nephrol Dial Transplant. 2003 Feb;18(2):426-8. No abstract available.

PMID:
12543902
13.

Urothelial malignant disease and Chinese herbal nephropathy.

Lord GM, Cook T, Arlt VM, Schmeiser HH, Williams G, Pusey CD.

Lancet. 2001 Nov 3;358(9292):1515-6.

PMID:
11705569
14.
15.

Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: clinical characteristics and outcomes.

Chen CH, Dickman KG, Huang CY, Moriya M, Shun CT, Tai HC, Huang KH, Wang SM, Lee YJ, Grollman AP, Pu YS.

Int J Cancer. 2013 Jul;133(1):14-20. doi: 10.1002/ijc.28013. Epub 2013 Feb 12.

16.

Increased mortality risk for cancers of the kidney and other urinary organs among Chinese herbalists.

Yang HY, Wang JD, Lo TC, Chen PC.

J Epidemiol. 2009;19(1):17-23. Epub 2009 Jan 22.

17.
18.

[Occupational risk factors for bladder carcinoma. A case control study].

Golka K, Bandel T, Reckwitz T, Urfer W, Bolt HM, Bremicker KD, Neugebauer W, Schulze H.

Urologe A. 1999 Jul;38(4):358-63. German.

PMID:
10444795
19.

Bladder cancer in dye manufacturing workers.

Boyko RW, Cartwright RA, Glashan RW.

J Occup Med. 1985 Nov;27(11):799-803.

PMID:
4067684
20.

An association of UDP-glucuronosyltransferase 2B7 C802T (His268Tyr) polymorphism with bladder cancer in benzidine-exposed workers in China.

Lin GF, Guo WC, Chen JG, Qin YQ, Golka K, Xiang CQ, Ma QW, Lu DR, Shen JH.

Toxicol Sci. 2005 May;85(1):502-6. Epub 2004 Dec 22.

PMID:
15615884

Supplemental Content

Support Center